Every year worldwide there are over 164 million blood and plasma donations that are commonly used in supportive care for cardiovascular and transplant surgery patients, trauma victims, and those undergoing cancer therapy.1,2 Ensuring access to a sufficient and safe supply of blood and blood-derived products is an international health priority that has been highlighted by the World Health Organization since 1975.3
Roche is a trusted partner for screening centers, with about one third of blood and plasma donated worldwide using blood safety solutions from Roche.4
One blood donation has the potential to save 3 lives5
Blood transfusion safety relies heavily on the accurate and timely screening of blood for transmissible infections. In addition, pathogens evolve and new ones emerge, demanding the need for continuous and robust test innovation and development. Safe blood transfusions save and transform lives.